Thursday, August 10, 2017

CyberKnife M6 Treatment by Premier Cancer Centers


Dr. Rajiv “Raj” Dahiya earned his medical degree from the University of Missouri Kansas City School of Medicine in 1994. A physician with Predictive Medical Solutions and Premier Cancer Centers in Dallas, TX, Dr. Raj Dahiya makes use of the latest cancer treatment solutions, including the CyberKnife® M6 system.

The CyberKnife® M6 FI System has been established as a leading solution in areas of full-body robotic radiosurgery and the precision and accuracy of CyberKnife® technology allows physicians to customize treatment for each individual patient. Medical professionals also benefit from the system’s advanced clinical features, which range from true robotic mobility to targeted tumor tracking with automatic correction capabilities.

The CyberKnife® system has effectively treated an array of medical conditions, including cancerous and non-cancerous lesions developing in the brain, lungs, liver, pancreas, and other areas of recurrent cancer. Individuals interested in learning more about the CyberKnife® M6 system can visit www.premiercancercenters.com.

Tuesday, August 1, 2017

Cyberknife M6 System - Patient Benefits


Having worked in the field of medicine for more than 20 years, Dr. Rajiv “Raj” Dahiya has served at several medical centers, including Premier Cancer Centers and Predictive Medical Solutions of Dallas, TX. Rajiv “Raj” Dahiya, MD, is trained in the newest advanced radiation therapy technologies, including the TomoTherapy H Series and the Cyberknife M6 System.

The Cyberknife M6 System gives medical professionals the ability to provide the most efficient treatment in full-body robotic radiosurgery. The system utilizes integrated software that helps guide physicians during the procedure, greatly reducing side effects and patient discomfort. The precision and pinpoint accuracy of the Cyberknife system also aids in recovery time by sparing the body's healthy tissue through sub-millimeter accuracy.

The modern sculpted design of the Cyberknife M6 System offers patients a no breath-hold, noninvasive experience while also providing a soothing environmental element to the treatment. The radiosurgery allows patients to breathe normally while lying in a comfortable position during treatment procedures.

Saturday, July 22, 2017

American Cancer Society Report Shows Ongoing Decline in Cancer Rates

 
A radiation oncologist with an MD from the University of Missouri - Kansas City School of Medicine, Dr. Rajiv “Raj” Dahiya works as a physician with Predictive Medical Solutions and Premier Cancer Centers in Dallas, TX. Beyond his day-to-day activities treating patients, Dr. Raj Dahiya maintains memberships with several organizations, including the American Cancer Society. 

Each year since 1998, the American Cancer Society has partnered with the North American Association of Central Cancer Registries, the Centers for Disease Control and Prevention, and the National Cancer Institute to produce the Annual Report to the Nation on the Status of Cancer. The report highlights new cancer cases and provides stats on death rates and cancer trends in the United States. 

According to the 2017 report, which was released in the Journal of the National Cancer Institute on March 31, cancer rates among men, women, and children continue to decline nationwide. The report also shows that survival rates for several types of cancer have increased significantly, even among those diagnosed with late-stage disease. 

The study authors point to advancements in early detection and treatment methods as well as a decline in tobacco use as the reasons for the decrease in overall cancer rates and increase in survival rates. With over 40 million American adults still smoking on a regular basis, however, the report highlights the need for continued efforts to reduce the number of American smokers even further.

Wednesday, July 12, 2017

TMA Presents First Health Hero Award


A graduate of the University of Missouri-Kansas City School of Medicine, Dr. Rajiv “Raj” Dahiya serves as a radiation oncologist at Premier Cancer Centers in Dallas, TX, where he makes use of tools such as the Predictive Medical Solutions Cyberknife to provide the very latest in radiation therapy tools to his patients. Engaged in the ongoing development and evolution of his profession, Dr. Raj Dahiya belongs to the Texas Medical Association.

Earlier this year, the Texas Medical Association (TMA) debuted a new “Health Hero” award designed to recognize organization members who have been key voices in its three major outreach initiatives: Be Wise-Immunize, Walks With a Doc Texas, and Hard Hats for Little Heads. The organization’s Council on Health Promotion, which serves as the oversight arm for all three initiatives, selected C. Leilani Valdes, MD, a pathologist from Victoria, Texas, as its first Health Hero award recipient.

Commenting on the selection, Dr. Valdes called it a “great honor” to be recognized as the first recipient. She also says she is excited about continuing to participate in the programs in the future, as she is passionate about these types of community awareness initiatives.

Thursday, June 29, 2017

American College of Radiology Holds 2017 Annual Meeting


An MD with Predictive Medical Solutions and Premier Cancer Centers in Dallas, TX, Dr. Rajiv “Raj” Dahiya specializes in radiation oncology. Throughout his medical career, Dr. Raj Dahiya has maintained affiliations with a number of professional groups, including the American College of Radiology (ACR). 

In its efforts to advance radiological care, the ACR offers members a variety of education programs and events throughout the year. The organization recently wrapped up its 2017 Annual Meeting, which took place May 21-25. 

Over 2,000 medical professionals attended the five-day event to take part in an education program comprising a variety of sessions organized into several broad knowledge pathways, including quality and safety, leadership, and clinical research. There were also a number of sessions for medical students, residents, and early-career physicians. 

Alongside the learning activities, the ACR 2017 Annual Meeting featured networking events, speed mentoring, an exhibit hall, and an advocacy day on Capitol Hill. Those who missed the event can access session content on the ACR website. ACR’s next Annual Meeting will be held May 20-24, 2018. Information about other upcoming events can be found at www.acr.org.

Sunday, June 18, 2017

ACR Launches New Leadership Course


Based in Dallas, TX, Dr. Rajiv “Raj” Dahiya uses minimally invasive techniques, such as the Predictive Medical Solutions Cyberknife, in his role as a radiation oncologist. In addition to his everyday radiation oncology work, Dr. Raj Dahiya is extremely active in his field through membership in numerous professional societies, including the American College of Radiology. 

This October, the American College of Radiology (ACR) will launch a new program aimed at equipping up-and-coming radiologists with the skills they need to step into leadership positions at their respective hospital posts. Dubbed the Radiology Leadership Institute (RLI), the 12-week course will provide informative instruction on topics such as hospital administration and governance, departmental leadership and accountability initiatives, and how to be a voice of positive change at a hospital.

The self-paced learning launches October 3, 2017, and runs until May 8, 2018. It will feature virtual courses as well as group discussion platforms that include expert faculty members.

Friday, June 9, 2017

ACS Says Prostate Cancer Screening Rates Have Stabilized


A graduate of the University of Missouri-Kansas City School of Medicine, Dr. Rajiv “Raj” Dahiya has worked at a number of facilities during his career, including at Predictive Medical Solutions, before taking his current job as a radiation oncologist at Premier Cancer Centers in Dallas, TX. Outside of his work as an MD, Dr. Raj Dahiya helps in the fight against cancer by supporting the efforts of the American Cancer Society.

According to researchers with the American Cancer Society, changes to screening recommendations which initially led to a decline in prostate specific antigen (PSA) tests now have less of an impact, with the decline now tapering off. When the US Preventive Services Task Force issued its recommendations against PSA testing in 2008, rates dropped by seven percent over a three-year period in men over the age of 50.

Recent research shows, however, that the screening rate has stabilized since 2015, with approximately 32.1 percent of men aged 50-plus receiving PSA screenings. Researchers attribute the stabilization to recent research indicating that older men are being diagnosed with prostate cancer at a slightly increased rate, prompting more men to get screened and others to be screened more frequently.